Epitomee Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	10	10	-	-	-
Gross Profit	10	10	-	-	-
Selling, General & Admin	3.37	2.79	3.28	2.6	0.74
Research & Development	5.83	6.8	7.79	6.18	3.1
Operating Expenses	2.16	9.58	11.07	8.77	3.85
Operating Income	7.84	0.42	-11.07	-8.77	-3.85
Interest Expense	-	-0.06	-	-2.71	-0.07
Interest & Investment Income	2.47	1.6	0.48	0.07	0.09
Currency Exchange Gain (Loss)	-0.46	-0.46	-4.9	-0.1	0.01
Other Non Operating Income (Expenses)	-0.01	-0.01	0.1	-	0.65
EBT Excluding Unusual Items	9.84	1.5	-15.39	-11.52	-3.17
Asset Writedown	-7.18	-7.18	-	-	-
Pretax Income	2.66	-5.68	-15.39	-11.52	-3.17
Net Income	2.66	-5.68	-15.39	-11.52	-3.17
Net Income to Common	2.66	-5.68	-15.39	-11.52	-3.17
Shares Outstanding (Basic)	30	30	29	2	0
Shares Outstanding (Diluted)	31	30	29	2	0
Shares Change (YoY)	4.96%	0.69%	1575.26%	669.53%	-
EPS (Basic)	0.09	-0.19	-0.52	-6.55	-13.86
EPS (Diluted)	0.09	-0.19	-0.52	-6.55	-13.86
Free Cash Flow	-11.99	-12	-13.12	-6.16	6.64
Free Cash Flow Per Share	-0.39	-0.40	-0.45	-3.50	29.08
Gross Margin	100.00%	100.00%	-	-	-
Operating Margin	78.38%	4.16%	-	-	-
Profit Margin	26.64%	-56.82%	-	-	-
Free Cash Flow Margin	-119.87%	-119.96%	-	-	-
EBITDA	7.88	0.63	-11.01	-8.72	-3.8
EBITDA Margin	78.82%	6.30%	-	-	-
D&A For EBITDA	0.04	0.21	0.06	0.05	0.05
EBIT	7.84	0.42	-11.07	-8.77	-3.85
EBIT Margin	78.38%	4.16%	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.